Small study aims to predict immunotherapy success in melanoma
NCT ID NCT03356470
First seen Jan 30, 2026 · Last updated May 14, 2026 · Updated 17 times
Summary
This study looked at 5 people with advanced melanoma to find markers that show if immunotherapy is working. Researchers used special PET scans and took blood and tumor samples before and during treatment with drugs like nivolumab or pembrolizumab. The goal was to see if changes in these markers could predict how well the tumor responds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.